Moderna
MRNA
#1416
Rank
A$19.71 B
Marketcap
$50.99
Share price
2.03%
Change (1 day)
-69.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$19.71 Billion

As of March 2025 Moderna has a market cap of A$19.71 Billion. This makes Moderna the world's 1416th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$19.71 B-20.6%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Mar 27th, 2025 the market cap of Moderna was reported to be:

A$19.67 Billion
by Nasdaq info icon info icon
A$19.71 Billion
by CompaniesMarketCap info icon info icon
A$19.71 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.15 B-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$351.25 B 1,681.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.32 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$55.68 B 182.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$349.25 B 1,671.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$3.00 B-84.74%๐Ÿ‡บ๐Ÿ‡ธ USA
A$624.02 B 3,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.72 B-76.02%๐Ÿ‡บ๐Ÿ‡ธ USA